β-D-Ribofuranose 1-Acetate 2,3,5-Tribenzoate CAS 6974-32-9 Assay ≥99.0% (HPLC) Clofarabine Intermediate High Purity

Lus piav qhia luv luv:

Lub npe: β-D-Ribofuranose 1-Acetate 2,3,5-Tribenzoate

CAS: 6974-32-9 Nr

Cov tsos mob: Dawb los yog Off-White Crystalline Hmoov

Kev ntsuam xyuas: ≥99.0% (HPLC)

Intermediate of Clofarabine (CAS: 123318-82-1) nyob rau hauv kev kho mob ntawm cov me nyuam nrog mob Lymphoblastic Leukemia (TXHUA)

Inquiry: alvin@ruifuchem.com


Product Detail

Yam khoom

Khoom cim npe

Nqe lus piav qhia:

Kev muag khoom lag luam Clofarabine Related Intermediates:
Clofarabine CAS TSIS .: 123318-82-1
Tom ntej: 2-Deoxy-2-fluoro-1,3,5-tri-O-benzoyl-α-D-arabinofuranose CAS: 97614-43-2
Tom ntej: Beta-D-Ribofuranose 1-Acetate 2,3,5-Tribenzoate CAS: 6974-32-9
Tom ntej: 1,3,5-Tri-O-benzoyl-D-Ribofuranose CAS: 22224-41-5
2,6-Dichloropurine CAS: 5451-40-1

Chemical Properties:

Tshuaj npe β-D-Ribofuranose 1-Acetate 2,3,5-Tribenzoate
Synonyms 1-O-Acetyl-2,3,5-tri-O-benzoyl-β-D-Ribofuranose
CAS Nr 6974-32-9
CAT Number Tus Qauv Zauv: RF-PI222
Tshuag xwm txheej Nyob rau hauv Tshuag, ntau lawm Scale mus txog Tons
Molecular Formula C28H24O9
Molecular Luj 504.49 ib
Hom Ruifu Tshuaj

Specifications:

Yam khoom Specifications
Qhov tshwm sim Dawb los yog Off-White Crystalline Hmoov
Assay / Analysis Method ≥99.0% (HPLC)
Melting Point 126.0 ~ 133.0 ℃
Poob rau ziab ≤0.50%
Residue ntawm Ignition ≤0.50%
Tag nrho cov impurities ≤ 1.00%
Hnyav Hlau ≤ 20ppm
Test Standard Enterprise Standard
Kev siv Pharmaceutical Intermediate ntawm Clofarabine CAS: 123318-82-1

Pob & Cia:

Pob: Lub raj mis, Aluminium ntawv ci hnab, Cardboard nruas, 25kg / Nruas, los yog raws li tus neeg yuav tsum tau muaj.

Cia txias:Khaws rau hauv cov thawv ntim khoom ntawm qhov chaw txias thiab qhuav;Tiv thaiv los ntawm lub teeb, noo noo thiab kab tsuag.

Qhov zoo:

1

FAQ:

12

Daim ntawv thov:

β-D-Ribofuranose 1-Acetate 2,3,5-Tribenzoate (CAS 6974-32-9) yog ib qho nruab nrab ntawm (Clofarabine CAS: 123318-82-1).Clofarabine (CAS: 123318-82-1) yog ib qho tshiab purine nucleoside anticancer tshuaj yog thawj zaug ua tiav los ntawm Top10 biopharmaceutical tuam txhab ntawm Tebchaws Meskas-Genzyme Corporation nrog cov npe lag luam yog "Clofarabine".Thaum Lub Kaum Ob Hlis 28, 2004 US Food and Drug Administration (FDA) tau siv ceev nrooj rau kev pom zoo ntawm clofarabine rau kev thov rau cov menyuam yaus uas muaj refractory lossis relapsed mob lymphocytic leukemia (TAG NRHO);nws muaj kev ua tau zoo heev ntawm kev kho mob leukemia nrog kev ua siab ntev thiab tsis muaj qhov cuam tshuam tsis zoo.Nws tuaj yeem raug tswj hwm los ntawm kev siv tshuaj intravenously lossis muab tshuaj ntawm qhov ncauj.Cov tshuaj no yog thawj cov khoom tau pom zoo rau kev mob siab rau kev kho mob ntawm cov menyuam yaus leukemia hauv ntau tshaj kaum xyoo.

Sau koj cov lus ntawm no thiab xa tuaj rau peb